In a recent study, the ubiquitin-specific protease 8 (USP8) has been shown to de-ubiquitinate PD-L1 in pancreatic cancer, demonstrating that USP8 intervention might increase PD-L1 blockade. Here, CD274 is linked to pancreatic neoplasm.